Steve Perrin PhD, CEO and CSO of ALS TDI, talks Gilenya, other emerging immunomodulators and their potential to treat ALS going forward. Read more: http://blogs.als.net/post/2013/02/12/Gilenya-giving-ALS-the-fingo.aspx

Gilenya, giving ALS the fingo?

ALS Today is an independent interactive news magazine featuring the latest research advances and potential therapies for ALS/MND. Published by ALS TDI, ALS Today informs clinicians, research scientists, patients and care providers about global efforts to end ALS. Find us online www.als.net/ALSToday. Follow us on Twitter @ALSToday.

Share Gilenya, giving ALS the fingo?

Sign up to save your podcasts

Gilenya, giving ALS the fingo?

Gilenya, giving ALS the fingo?